Children with Ulcerative Colitis May Be Safely Treated with Multimatrix Mesalamine

Children with Ulcerative Colitis May Be Safely Treated with Multimatrix Mesalamine
A study from the Johns Hopkins University School of Medicine reported that children and adolescents with ulcerative colitis (UC) reacted to multimatrix mesalamine treatment in ways similar to adults, with the drug showing a good safety and tolerability profile in all age and dose groups examined. The study, “Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *